Sartorius Stedim Biotech S.A. Profit Margin

Sartorius Stedim Biotech S.A. (DIM.PA) currently reports a profit margin of 10.27% as of September 2026. That compares with 8.96% in the prior-year period — up 14.6% year over year. That is below the sector sector average of 13.23%. Use the charts on this page to explore Sartorius Stedim Biotech S.A.'s profit margin history and peer comparisons.

Sartorius Stedim Biotech S.A.'s profit margin increased from 8.96% to 10.27% — a 14.6% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sartorius Stedim Biotech S.A.'s profit margin of 10.27% is lower than the its sector sector average of 13.23%. That is roughly 22.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Sartorius Stedim Biotech S.A.'s current 10.27% should be judged against industry norms (sector average: 13.23%) and against DIM.PA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 10.27%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Sartorius Stedim Biotech S.A., and consider following DIM.PA for alerts when major investors trade the stock.